Literature DB >> 28039657

Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program.

Aimee L Lucas1, Adam Tarlecki2, Kellie Van Beck2, Casey Lipton3, Arindam RoyChoudhury4, Elana Levinson5, Sheila Kumar6, Wendy K Chung7,8, Harold Frucht3, Jeanine M Genkinger2,8.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death; approximately 5-10% of PDAC is hereditary. Self-administered health history questionnaires (HHQs) may provide a low-cost method to detail family history (FH) of malignancy. Pancreas Center patients were asked to enroll in a registry; 149 with PDAC completed a HHQ which included FH data. Patients with FH of PDAC, or concern for inherited PDAC syndrome, were separately evaluated in a Prevention Program and additionally met with a genetic counselor (GC) to assess PDAC risk (n = 61). FH obtained through GC and HHQ were compared using Wilcoxon signed-rank sum and generalized linear mixed models with Poisson distribution. Agreement between GC and HHQ risk-assessment was assessed using kappa (κ) statistic. In the Prevention Program, HHQ was as precise in detecting FH of cancer as the GC (all p > 0.05). GC and HHQ demonstrated substantial agreement in risk-stratification of the Prevention Program cohort (κ = 0.73, 95% CI 0.59-0.87.) The sensitivity of the HHQ to detect a patient at elevated risk (i.e., moderate- or high-risk) of PDAC, compared to GC, was 82.9% (95% CI 67.3-92.3%) with a specificity of 95% (95% CI 73.1-99.7%). However, seven patients who were classified as average-risk by the HHQ were found to be at an elevated-risk of PDAC by the GC. In the PDAC cohort, 30/149 (20.1%) reported at least one first-degree relative (FDR) with PDAC. The limited sensitivity of the HHQ to detect patients at elevated risk of PDAC in the Prevention Program cohort suggests that a GC adds value in risk-assessment in this population. The HHQ may offer an opportunity to identify high-risk patients in a PDAC population.

Entities:  

Keywords:  Genetic counselor; Health history questionnaire; Hereditary pancreatic cancer; Pancreatic cancer; Pancreatic ductal adenocarcinoma

Mesh:

Year:  2016        PMID: 28039657      PMCID: PMC5498249          DOI: 10.1007/s10897-016-0057-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  38 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

2.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

3.  Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).

Authors:  Dominique S Michaud; Alina Vrieling; Li Jiao; Julie B Mendelsohn; Emily Steplowski; Shannon M Lynch; Jean Wactawski-Wende; Alan A Arslan; H Bas Bueno-de-Mesquita; Charles S Fuchs; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea Lacroix; Gloria Petersen; Wei Zheng; Naomi Allen; Laufey Ammundadottir; Manuela M Bergmann; Paolo Boffetta; Julie E Buring; Federico Canzian; Stephen J Chanock; Françoise Clavel-Chapelon; Sandra Clipp; Matthew S Freiberg; J Michael Gaziano; Edward L Giovannucci; Susan Hankinson; Patricia Hartge; Robert N Hoover; F Allan Hubbell; David J Hunter; Amy Hutchinson; Kevin Jacobs; Charles Kooperberg; Peter Kraft; Jonas Manjer; Carmen Navarro; Petra H M Peeters; Xiao-Ou Shu; Victoria Stevens; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Rosario Tumino; Paolo Vineis; Jarmo Virtamo; Robert Wallace; Brian M Wolpin; Kai Yu; Anne Zeleniuch-Jacquotte; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

Review 4.  Familial pancreatic cancer.

Authors:  A P Klein; R H Hruban; K A Brune; G M Petersen; M Goggins
Journal:  Cancer J       Date:  2001 Jul-Aug       Impact factor: 3.360

5.  The prevalence of BRCA2 mutations in familial pancreatic cancer.

Authors:  Fergus J Couch; Michele R Johnson; Kari G Rabe; Kieran Brune; Mariza de Andrade; Michael Goggins; Heidi Rothenmund; Steven Gallinger; Alison Klein; Gloria M Petersen; Ralph H Hruban
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

6.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

Review 7.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Risk of pancreatic cancer in families with Lynch syndrome.

Authors:  Fay Kastrinos; Bhramar Mukherjee; Nabihah Tayob; Fei Wang; Jennifer Sparr; Victoria M Raymond; Prathap Bandipalliam; Elena M Stoffel; Stephen B Gruber; Sapna Syngal
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

9.  Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Authors:  Kathleen M Murphy; Kieran A Brune; Constance Griffin; Jennifer E Sollenberger; Gloria M Petersen; Ravi Bansal; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.

Authors:  Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

View more
  1 in total

1.  Comparison of a Focused Family Cancer History Questionnaire to Family History Documentation in the Electronic Medical Record.

Authors:  Kristin Clift; Sarah Macklin-Mantia; Margaret Barnhorst; Lindsey Millares; Zacharay King; Anjali Agarwal; Richard John Presutti
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.